Adam Kittai, MD, discusses how value and waste in treatment are imperative to consider in value-based care for blood-based cancers.
Maximizing the value of treatment and ensuring that money is spent wisely are 2 important aspects to consider in value-based care for blood-based cancer, explains Adam Kittai, MD, assistant professor in the division of hematology at The Ohio State University-James Cancer Hospital and Solove Research Institute.
Transcript
Why is value-based care important when treating patients with a blood-based cancer such as leukemia?
I think there are 2 main reasons why value-based care is important here. One, for anyone that has a malignancy, it's important that the patient can derive as much value as they can from the treatment they receive, and with the time that they have. Life is uncertain in any circumstance, and when you are dealing with a serious life event, like cancer, deriving value from what we have is made a very high priority.
Your other reason is cost and waste. As these new drugs are being developed for hematologic malignancies, the cost of cancer is rising exponentially. So, as costs are rising, it puts a significant stress on our health care system overall. It also creates disparities in access to care.
Higher costs also lead to higher wastes, and it's important that we derive as much value as we can from every dollar spent, given money is not an unlimited commodity, allowing us to not only take great care of the patient in front of us, but all but all of society as a whole.
When I think about why value-based care is important when treating patients with a blood-based cancer, I think the 2 main things that I can think of are that we really want to derive as much value of the time that we have and the treatment that we give, and also really think about the cost of the care that we give.
Managed Care Reflections: A Q&A With Hoangmai H. Pham, MD, MPH
April 1st 2025To mark the 30th anniversary of The American Journal of Managed Care® (AJMC®), each issue in 2025 will include a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The April issue features a conversation with Hoangmai H. Pham, MD, MPH, a member of AJMC’s editorial board and the president and CEO of the Institute for Exceptional Care (IEC).
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More
Dermatologists Advocating for Inclusive Hair Loss Research and Treatment in the African Diaspora
March 26th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, advocates for increased funding and education to address hair loss disparities within the African diaspora, emphasizing the need for culturally sensitive treatment and research.
Read More